Developer docs
API playgroundTry for free, no card

Search company profiles

The Dunn Lab

Full company profile

uuid002sepn

Namestring
The Dunn Lab
Legal namestring
The Dunn Lab (Purdue University)
Websiteurl
thedunnlab.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

The Dunn Lab is an academic research laboratory housed at Purdue University (Indianapolis campus), directed by Dr. Erin C. Dunn. The lab investigates the etiology of depression and related psychiatric and neurodevelopmental conditions, with a particular emphasis on how early-life stress exposure shapes mental-health risk across the life course. Its work spans psychiatric and neurodevelopmental genetics, epigenetics, developmental epidemiology, and intergenerational transmission, with a stated focus on women, children, and adolescents.

The lab's signature methodological contribution is the use of deciduous (baby) teeth as biomarkers that record cumulative early-life exposure to stress, paired with genetic and epigenetic assays to identify sensitive developmental periods and biological mechanisms underlying depression risk. It operates multiple cohort-based studies, including the prospective STRONG Study and collaborations on the Avon Longitudinal Study of Parents and Children (ALSPAC) and the Growing Up in Singapore Towards Healthy Outcomes (GUSTO) cohort. Outputs include peer-reviewed publications, trainee mentorship, and a public engagement platform at teethforscience.com.

The lab is non-commercial and operates under the standard academic funding model: it secures competitive grants from federal agencies (notably NIH/NIMH) and private foundations (including the Jacobs Foundation, Russell Sage Foundation, Robert Wood Johnson Foundation, One Mind, and the Brain & Behavior Research Foundation), and produces no product revenue. Its 'customers' in the conventional sense are research participants, trainees, and the broader scientific and public-health community.

Short descriptiontext

The Dunn Lab is an academic research laboratory at Purdue University that studies the genetic, epigenetic, and developmental origins of depression and related conditions, using baby teeth biomarkers and longitudinal birth cohorts to identify sensitive periods of early-life stress exposure.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychiatric genetics research, epigenetics studies, mental health research, developmental epidemiology, depression prevention research
Industry2 codes
PRIMARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Academic Mental Health Research
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Research Grant Funding
TypeOthers
Description

The lab operates as a university research laboratory funded primarily through competitive grants from federal agencies (NIH/NIMH), private foundations, and institutional sources. Funding supports ongoing studies, data collection, team members, and generating preliminary results to compete for larger grants.

thedunnlab.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Dunn Lab conducts interdisciplinary academic research investigating how genetic variation, epigenetic mechanisms, and early-life environmental stressors shape depression risk and resilience among women, children, and adolescents. Its distinctive approach includes pioneering the use of baby teeth as non-invasive biomarkers for mental illness risk and identifying sensitive developmental periods when interventions can be optimally timed to prevent depression before symptom onset. The lab does not sell commercial products or services; it disseminates findings through peer-reviewed publications, scientific collaborations, and public education.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Led pioneering genetic and gene-environment interaction studies, including some of the first GWAS of depression risk in non-European ancestry populations and the first genome-wide environment interaction study of depression.
+2 more records
Product overview1 text field

The Dunn Lab is a research laboratory at Purdue University, not a commercial product company. The lab conducts interdisciplinary mental health research through five interconnected research studies: Depression, Epigenetics, Sensitive Periods, Teeth (biomarkers), and the STRONG Study. These studies collectively aim to identify strategies to reduce the burden of mental illness and promote lifelong brain health by investigating genetic variation, epigenetic mechanisms, and early-life environmental stressors. The lab also maintains a public educational resource at teethforscience.com.

Product and service6 records
1Depression Research Study
CategoryResearch Study
Description

Investigation into how genetic variation and life experiences combine to shape both risk and resilience to depression, examining stress as a key risk factor. Targeted at advancing scientific understanding of depression etiology.

2Epigenetics Research Study
CategoryResearch Study
Description

Study of how early adversity leaves lasting biological memories through epigenetic changes like DNA methylation, impacting depression risk from childhood to adulthood. Designed for the scientific community studying biological mechanisms of mental health.

3Sensitive Periods Research Study
CategoryResearch Study
Description

Research identifying sensitive periods—times of heightened brain plasticity—when experiences can have lasting effects on mental health, spanning prenatal development through adulthood. Aimed at informing timing of preventive interventions.

4Teeth as Biomarkers Research
CategoryResearch Study
Description

Exploration of baby teeth as novel, less invasive biomarkers for mental illness risk, leveraging teeth as widely available biospecimens that preserve chronological growth records reflecting early-life stress exposure.

5STRONG Study
CategoryResearch Study
Description

A longitudinal study examining whether baby teeth can reveal clues about childhood adversity and future mental health risk through collection and analysis of primary exfoliated teeth from participants.

6teethforscience.com Public Educational Resource
CategoryPublic Educational Resource
Description

Public-facing website providing information about the lab's research using teeth, including why teeth are promising biomarkers for mental health risk. Intended for the general public, study participants, and the broader scientific community.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborator Kerry J. Ressler is affiliated with McLean Hospital and Harvard Medical School. The lab collaborates on genetic and epigenetic studies of depression and trauma.

2Charlotte Cecil - Erasmus MC Sophia Children's Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on genetics/epigenetics research, focusing on child development and mental health.

thedunnlab.com
3Anke Huels - Emory University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on environmental epigenetics and biostatistics research.

thedunnlab.com
4Luke Hyde - University of Michigan
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on developmental psychology, brain architecture, and mental health research.

thedunnlab.com
5Alexandre Lussier - Massachusetts General Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-term collaborator on epigenetics, DNA methylation, and sensitive period research. A former post-doctoral research fellow in the lab who continues collaborative work.

thedunnlab.com
6Colter Mitchell - University of Michigan
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on population studies linking early life adversity to biological and mental health outcomes.

thedunnlab.com
7Kerry J. Ressler - McLean Hospital & Harvard Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on genetic and epigenetic mechanisms linking childhood adversity to depression and PTSD.

thedunnlab.com
8Andrew Simpkin - University of Galway
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on statistical methodology and epigenetic analyses.

thedunnlab.com
9Andrew Smith - University of the West of England
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborates on statistical and computational approaches to epigenetics research.

thedunnlab.com
10Dan Stein - University of Cape Town
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on psychiatric genetics and epidemiology, bringing global health perspectives to the research.

thedunnlab.com
11Matt Suderman - University of Bristol
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on DNA methylation and epigenetic aging research.

thedunnlab.com
12Esther Walton - University of Bath
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on epigenetics, statistical methods, and developmental origins of health and disease.

thedunnlab.com
13Debbie Guatelli-Steinberg - The Ohio State University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dental and craniofacial anthropology expert collaborating on baby teeth biomarker research. Focuses on enamel and dentine development.

thedunnlab.com
14Marcy Kingsbury - Harvard Medical School / Massachusetts General Hospital
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborates on dental and craniofacial aspects of the baby teeth research program.

thedunnlab.com
15Mary Marazita - University of Pittsburgh
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborates on genetic and dental research relevant to the baby teeth biomarker program.

thedunnlab.com
16Simone Lemmers - Harvard Medical School & Massachusetts General Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on the STRONG Study and analysis of baby teeth as biomarkers, including histological data collection and tooth section analysis.

thedunnlab.com
17Mona Le Luyer - Harvard Catalyst / Mass General Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biological anthropologist who joined the lab to lead efforts analyzing baby teeth. Previously collaborated via Harvard Catalyst on the STRONG Study.

thedunnlab.com
18Kristen Choi - University of California, Los Angeles
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on childhood adversity research, including studies on adversity co-occurrence and its health consequences.

thedunnlab.com
19Josh Roffman - Massachusetts General Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on prenatal and early life factors affecting brain development and mental health risk.

thedunnlab.com
20Altaf Saadi - Massachusetts General Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates on childhood adversity, social determinants of health, and their intersection with mental health outcomes.

thedunnlab.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1McCance Center for Brain Health at MGH
TypeDirect peer
Description

Prior institutional home of Dr. Dunn and a former funding partner. Focuses on brain health resilience and prevention research, sharing the Dunn Lab's mission of preventing psychiatric illness before onset.

2Stanley Center for Psychiatric Research at the Broad Institute
TypeDirect peer
Description

Academic research center conducting large-scale psychiatric genetics and genomics research on disorders including depression. Closest direct peer in scale, methodology, and mission - both labs pursue GWAS and functional genomics to understand mental illness.

TypeDirect peer
Description

Nonprofit research organization conducting large-scale brain and mental health research with open-science outputs. Comparable in mission scope, interdisciplinary model, and public-research orientation.

TypeDirect peer
Description

Leading European academic research center for psychiatric genetics, running large-scale GWAS and epigenetic studies on depression, schizophrenia, and related disorders. Methodological peer.

TypeBroad incumbent
Description

Nonprofit genomics research institute with broader disease focus (oncology, neurological, infectious disease). Comparable in nonprofit research model and genomic methodology, but with wider therapeutic-area scope.

TypeBroad incumbent
Description

Established genetics research company (now part of Amgen) conducting population-scale GWAS and genomic studies in Icelandic cohorts. Comparable in human genetic discovery methodology but operates at much larger scale with commercial scope.

7Center for Genomic Medicine at Massachusetts General Hospital
TypeDirect peer
Description

Major academic genomic medicine center where Dr. Dunn held prior affiliations. Conducts genetic and epigenetic research on psychiatric and neurological disorders using similar longitudinal cohort and methylation methodologies.

TypeEmerging player
Description

Nonprofit biomedical research organization focused on computational approaches to multi-omic data, including psychiatric and neurodegenerative research. Overlaps with Dunn Lab's epigenomic and data-analysis methodologies.

TypeBroad incumbent
Description

Large academic sequencing center that conducts population-scale genetic studies overlapping with psychiatric genomics. Comparable in scale and large-cohort methodology, broader in disease focus.

TypeDirect peer
Description

International consortium coordinating psychiatric genetic studies across hundreds of institutions. The Dunn Lab's GWAS work contributes to PGC's depression working group, making it a key collaborative peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Dunn Lab

Academic Mental Health Researchthedunnlab.com

The Dunn Lab is an academic research laboratory at Purdue University that studies the genetic, epigenetic, and developmental origins of depression and related conditions, using baby teeth biomarkers and longitudinal birth cohorts to identify sensitive periods of early-life stress exposure.

What The Dunn Lab does

The Dunn Lab is an academic research laboratory housed at Purdue University (Indianapolis campus), directed by Dr. Erin C. Dunn. The lab investigates the etiology of depression and related psychiatric and neurodevelopmental conditions, with a particular emphasis on how early-life stress exposure shapes mental-health risk across the life course. Its work spans psychiatric and neurodevelopmental genetics, epigenetics, developmental epidemiology, and intergenerational transmission, with a stated focus on women, children, and adolescents.

The lab's signature methodological contribution is the use of deciduous (baby) teeth as biomarkers that record cumulative early-life exposure to stress, paired with genetic and epigenetic assays to identify sensitive developmental periods and biological mechanisms underlying depression risk. It operates multiple cohort-based studies, including the prospective STRONG Study and collaborations on the Avon Longitudinal Study of Parents and Children (ALSPAC) and the Growing Up in Singapore Towards Healthy Outcomes (GUSTO) cohort. Outputs include peer-reviewed publications, trainee mentorship, and a public engagement platform at teethforscience.com.

The lab is non-commercial and operates under the standard academic funding model: it secures competitive grants from federal agencies (notably NIH/NIMH) and private foundations (including the Jacobs Foundation, Russell Sage Foundation, Robert Wood Johnson Foundation, One Mind, and the Brain & Behavior Research Foundation), and produces no product revenue. Its 'customers' in the conventional sense are research participants, trainees, and the broader scientific and public-health community.

The Dunn Lab firmographics

Firmographics
Name
The Dunn Lab
Legal name
The Dunn Lab (Purdue University)
Website
https://thedunnlab.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
The Dunn Lab is an academic research laboratory at Purdue University that studies the genetic, epigenetic, and developmental origins of depression and related conditions, using baby teeth biomarkers and longitudinal birth cohorts to identify sensitive periods of early-life stress exposure.
Ownership category
akta.pro rank

The Dunn Lab industry classification

Industry
Product category
Academic Mental Health Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Keywords

  • Psychiatric genetics research
  • Epigenetics studies
  • Mental health research
  • Developmental epidemiology
  • Depression prevention research

Where The Dunn Lab is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices2 records

Markets served

The Dunn Lab business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Research Grant Funding: The lab operates as a university research laboratory funded primarily through competitive grants from federal agencies (NIH/NIMH), private foundations, and institutional sources. Funding supports ongoing studies, data collection, team members, and generating preliminary results to compete for larger grants.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

The Dunn Lab product offering

Product offering

Core offering

The Dunn Lab conducts interdisciplinary academic research investigating how genetic variation, epigenetic mechanisms, and early-life environmental stressors shape depression risk and resilience among women, children, and adolescents. Its distinctive approach includes pioneering the use of baby teeth as non-invasive biomarkers for mental illness risk and identifying sensitive developmental periods when interventions can be optimally timed to prevent depression before symptom onset. The lab does not sell commercial products or services; it disseminates findings through peer-reviewed publications, scientific collaborations, and public education.

Product overview

The Dunn Lab is a research laboratory at Purdue University, not a commercial product company. The lab conducts interdisciplinary mental health research through five interconnected research studies: Depression, Epigenetics, Sensitive Periods, Teeth (biomarkers), and the STRONG Study. These studies collectively aim to identify strategies to reduce the burden of mental illness and promote lifelong brain health by investigating genetic variation, epigenetic mechanisms, and early-life environmental stressors. The lab also maintains a public educational resource at teethforscience.com.

Differentiator

Problem solved

Functional benefit

Products and services

  • Depression Research Study Investigation into how genetic variation and life experiences combine to shape both risk and resilience to depression, examining stress as a key risk factor. Targeted at advancing scientific understanding of depression etiology.
  • Epigenetics Research Study Study of how early adversity leaves lasting biological memories through epigenetic changes like DNA methylation, impacting depression risk from childhood to adulthood. Designed for the scientific community studying biological mechanisms of mental health.
  • Sensitive Periods Research Study Research identifying sensitive periods—times of heightened brain plasticity—when experiences can have lasting effects on mental health, spanning prenatal development through adulthood. Aimed at informing timing of preventive interventions.
  • Teeth as Biomarkers Research Exploration of baby teeth as novel, less invasive biomarkers for mental illness risk, leveraging teeth as widely available biospecimens that preserve chronological growth records reflecting early-life stress exposure.
  • STRONG Study A longitudinal study examining whether baby teeth can reveal clues about childhood adversity and future mental health risk through collection and analysis of primary exfoliated teeth from participants.
  • teethforscience.com Public Educational Resource Public-facing website providing information about the lab's research using teeth, including why teeth are promising biomarkers for mental health risk. Intended for the general public, study participants, and the broader scientific community.

Quantifiable outcome

  • Led pioneering genetic and gene-environment interaction studies, including some of the first GWAS of depression risk in non-European ancestry populations and the first genome-wide environment interaction study of depression.
  • +2 more outcomes

Companies that use The Dunn Lab

Customer profile

Segments2 records

Ideal customer profiles4 records

The Dunn Lab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

The Dunn Lab partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and minor.

  • McLean Hospital & Harvard Medical SchoolcoreStrategic or Co-development PartnerCollaborator Kerry J. Ressler is affiliated with McLean Hospital and Harvard Medical School. The lab collaborates on genetic and epigenetic studies of depression and trauma.
  • Charlotte Cecil - Erasmus MC Sophia Children's HospitalcoreStrategic or Co-development PartnerCollaborates on genetics/epigenetics research, focusing on child development and mental health.
  • Anke Huels - Emory UniversitycoreStrategic or Co-development PartnerCollaborates on environmental epigenetics and biostatistics research.
  • Luke Hyde - University of MichigancoreStrategic or Co-development PartnerCollaborates on developmental psychology, brain architecture, and mental health research.
  • Alexandre Lussier - Massachusetts General HospitalcoreStrategic or Co-development PartnerLong-term collaborator on epigenetics, DNA methylation, and sensitive period research. A former post-doctoral research fellow in the lab who continues collaborative work.
  • Colter Mitchell - University of MichigancoreStrategic or Co-development PartnerCollaborates on population studies linking early life adversity to biological and mental health outcomes.
  • Kerry J. Ressler - McLean Hospital & Harvard Medical SchoolcoreStrategic or Co-development PartnerCollaborates on genetic and epigenetic mechanisms linking childhood adversity to depression and PTSD.
  • Andrew Simpkin - University of GalwaycoreStrategic or Co-development PartnerCollaborates on statistical methodology and epigenetic analyses.
  • Andrew Smith - University of the West of EnglandminorStrategic or Co-development PartnerCollaborates on statistical and computational approaches to epigenetics research.
  • Dan Stein - University of Cape TowncoreStrategic or Co-development PartnerCollaborates on psychiatric genetics and epidemiology, bringing global health perspectives to the research.
  • Matt Suderman - University of BristolcoreStrategic or Co-development PartnerCollaborates on DNA methylation and epigenetic aging research.
  • Esther Walton - University of BathcoreStrategic or Co-development PartnerCollaborates on epigenetics, statistical methods, and developmental origins of health and disease.
  • Debbie Guatelli-Steinberg - The Ohio State UniversitycoreStrategic or Co-development PartnerDental and craniofacial anthropology expert collaborating on baby teeth biomarker research. Focuses on enamel and dentine development.
  • Marcy Kingsbury - Harvard Medical School / Massachusetts General HospitalminorStrategic or Co-development PartnerCollaborates on dental and craniofacial aspects of the baby teeth research program.
  • Mary Marazita - University of PittsburghminorStrategic or Co-development PartnerCollaborates on genetic and dental research relevant to the baby teeth biomarker program.
  • Simone Lemmers - Harvard Medical School & Massachusetts General HospitalcoreStrategic or Co-development PartnerCollaborates on the STRONG Study and analysis of baby teeth as biomarkers, including histological data collection and tooth section analysis.
  • Mona Le Luyer - Harvard Catalyst / Mass General HospitalcoreStrategic or Co-development PartnerBiological anthropologist who joined the lab to lead efforts analyzing baby teeth. Previously collaborated via Harvard Catalyst on the STRONG Study.
  • Kristen Choi - University of California, Los AngelescoreStrategic or Co-development PartnerCollaborates on childhood adversity research, including studies on adversity co-occurrence and its health consequences.
  • Josh Roffman - Massachusetts General HospitalcoreStrategic or Co-development PartnerCollaborates on prenatal and early life factors affecting brain development and mental health risk.
  • Altaf Saadi - Massachusetts General HospitalcoreStrategic or Co-development PartnerCollaborates on childhood adversity, social determinants of health, and their intersection with mental health outcomes.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

The Dunn Lab competitors and assessment

Company assessment

Direct peers

  • McCance Center for Brain Health at MGH: Prior institutional home of Dr. Dunn and a former funding partner. Focuses on brain health resilience and prevention research, sharing the Dunn Lab's mission of preventing psychiatric illness before onset.
  • Stanley Center for Psychiatric Research at the Broad Institute: Academic research center conducting large-scale psychiatric genetics and genomics research on disorders including depression. Closest direct peer in scale, methodology, and mission - both labs pursue GWAS and functional genomics to understand mental illness.
  • Allen Institute for Brain Science: Nonprofit research organization conducting large-scale brain and mental health research with open-science outputs. Comparable in mission scope, interdisciplinary model, and public-research orientation.
  • MRC Centre for Neuropsychiatric Genetics and Genomics (Cardiff University): Leading European academic research center for psychiatric genetics, running large-scale GWAS and epigenetic studies on depression, schizophrenia, and related disorders. Methodological peer.
  • Center for Genomic Medicine at Massachusetts General Hospital: Major academic genomic medicine center where Dr. Dunn held prior affiliations. Conducts genetic and epigenetic research on psychiatric and neurological disorders using similar longitudinal cohort and methylation methodologies.
  • Psychiatric Genomics Consortium (PGC): International consortium coordinating psychiatric genetic studies across hundreds of institutions. The Dunn Lab's GWAS work contributes to PGC's depression working group, making it a key collaborative peer.

Broad incumbents

  • Translational Genomics Research Institute (TGen): Nonprofit genomics research institute with broader disease focus (oncology, neurological, infectious disease). Comparable in nonprofit research model and genomic methodology, but with wider therapeutic-area scope.
  • deCODE genetics (Amgen): Established genetics research company (now part of Amgen) conducting population-scale GWAS and genomic studies in Icelandic cohorts. Comparable in human genetic discovery methodology but operates at much larger scale with commercial scope.
  • Human Genome Sequencing Center (Baylor College of Medicine): Large academic sequencing center that conducts population-scale genetic studies overlapping with psychiatric genomics. Comparable in scale and large-cohort methodology, broader in disease focus.

Emerging players

  • Sage Bionetworks: Nonprofit biomedical research organization focused on computational approaches to multi-omic data, including psychiatric and neurodegenerative research. Overlaps with Dunn Lab's epigenomic and data-analysis methodologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

The Dunn Lab social profiles

Digital presence

The Dunn Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Dunn Lab leadership team

Management profile

Number of profiles

Profiles10 records

The Dunn Lab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Dunn Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Dunn Lab

What does The Dunn Lab do?

The Dunn Lab conducts interdisciplinary academic research investigating how genetic variation, epigenetic mechanisms, and early-life environmental stressors shape depression risk and resilience among women, children, and adolescents. Its distinctive approach includes pioneering the use of baby teeth as non-invasive biomarkers for mental illness risk and identifying sensitive developmental periods when interventions can be optimally timed to prevent depression before symptom onset. The lab does not sell commercial products or services; it disseminates findings through peer-reviewed publications, scientific collaborations, and public education.

Is The Dunn Lab a public or private company?

The Dunn Lab is a private company. It is classified as state government owned and is currently operating.

When was The Dunn Lab founded?

The Dunn Lab was founded in -1. It employs 1 to 10 people.

Where is The Dunn Lab based?

The Dunn Lab is headquartered in Cambridge, United States, in the North America region.

How does The Dunn Lab make money?

One revenue line is on record: research Grant Funding.

Who are The Dunn Lab's main competitors?

Direct peers on record are McCance Center for Brain Health at MGH, Stanley Center for Psychiatric Research at the Broad Institute, Allen Institute for Brain Science, MRC Centre for Neuropsychiatric Genetics and Genomics (Cardiff University), Center for Genomic Medicine at Massachusetts General Hospital and Psychiatric Genomics Consortium (PGC). Broad incumbents are Translational Genomics Research Institute (TGen), deCODE genetics (Amgen) and Human Genome Sequencing Center (Baylor College of Medicine). Sage Bionetworks is listed as an emerging player.

Does The Dunn Lab have an API?

No public API is recorded for The Dunn Lab.

What industry is The Dunn Lab in?

The Dunn Lab's product category is Academic Mental Health Research. Its primary akta.pro industry code is HLAAANAL, Population Genomics & Preventive Precision Health Programs, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales